
According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease.
The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic stroke,” was published online last week in the journal Cell Metabolism.
Advertisement
Ischemic stroke occurs when a blood clot or other blockage obstructs a cerebral blood vessel, cutting off oxygen and nutrients and causing brain cells to die.
Advertisement
Survivors often suffer severe aftereffects, including motor disabilities and cognitive decline. Treatment is further complicated by a narrow three-hour “golden time” window after symptom onset, during which patients must receive emergency care.

Don't Miss:
-
Zelensky says Ukraine drones hit oil refinery in Russia’s Tyumen, now have 3,000km range
-
Trump blames reflecting pool woes on vandalism, but offers no proof
-
Ubisoft co-founder Claude Guillemot dies in plane crash in France
-
Heavy Petting Mixed In With Some Fire
-
Russia frees 24 Filipinos after Marcos speaks with Putin

India’s Zojila Tunnel Shores up Defense Posture in Himalayas
The Government Knows the Problem but Life not Getting Better
Cambodian Cyber Tycoon and ‘Singapore Washing’